| Translating IL-6 biology into effective treatments EH Choy, F De Benedetti, T Takeuchi, M Hashizume, MR John, ... Nature Reviews Rheumatology 16 (6), 335-345, 2020 | 594 | 2020 |
| Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1–84: implications for improvement of accurate assessment of … P Gao, S Scheibel, P D'Amour, MR John, SD Rao, H Schmidt‐Gayk, ... Journal of Bone and Mineral Research 16 (4), 605-614, 2001 | 421 | 2001 |
| A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure MR John, WG Goodman, P Gao, TL Cantor, IB Salusky, H Jüppner The Journal of Clinical Endocrinology & Metabolism 84 (11), 4287-4290, 1999 | 346 | 1999 |
| Human PTH-(7-84) Inhibits Bone Resorption in Vitro Via Actions Independent of the Type 1 PTH/PTHrP Receptor P Divieti, MR John, H Juppner, FR Bringhurst Endocrinology 143 (1), 171-176, 2002 | 243 | 2002 |
| Rapid and robust response of biochemical markers of bone formation to teriparatide therapy SJ Glover, R Eastell, EV McCloskey, A Rogers, P Garnero, J Lowery, ... Bone 45 (6), 1053-1058, 2009 | 186 | 2009 |
| Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised … GR Burmester, F Buttgereit, C Bernasconi, JM Álvaro-Gracia, N Castro, ... The Lancet 396 (10246), 267-276, 2020 | 121 | 2020 |
| Quantitative MRI measures of cartilage predict knee replacement: a case–control study from the Osteoarthritis Initiative F Eckstein, CK Kwoh, RM Boudreau, Z Wang, MJ Hannon, S Cotofana, ... Annals of the rheumatic diseases 72 (5), 707-714, 2013 | 115 | 2013 |
| Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials MA Karsdal, K Henriksen, AC Bay‐Jensen, B Molloy, M Arnold, MR John, ... The Journal of Clinical Pharmacology 51 (4), 460-471, 2011 | 112 | 2011 |
| Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year? FW Roemer, CK Kwoh, MJ Hannon, DJ Hunter, F Eckstein, Z Wang, ... Radiology 274 (3), 810-820, 2015 | 107 | 2015 |
| Direct comparison of fixed flexion, radiography and MRI in knee osteoarthritis: responsiveness data from the Osteoarthritis Initiative W Wirth, J Duryea, MPH Le Graverand, MR John, M Nevitt, RJ Buck, ... Osteoarthritis and cartilage 21 (1), 117-125, 2013 | 91 | 2013 |
| Greater rates of cartilage loss in painful knees than in pain‐free knees after adjustment for radiographic disease stage: Data from the Osteoarthritis Initiative F Eckstein, S Cotofana, W Wirth, M Nevitt, MR John, D Dreher, R Frobell, ... Arthritis & Rheumatism 63 (8), 2257-2267, 2011 | 80 | 2011 |
| Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues MR John, M Arai, DA Rubin, KB Jonsson, H Jüppner Endocrinology 143 (3), 1047-1057, 2002 | 62 | 2002 |
| 1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists L Widler, E Altmann, R Beerli, W Breitenstein, R Bouhelal, T Buhl, ... Journal of medicinal chemistry 53 (5), 2250-2263, 2010 | 60 | 2010 |
| Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces A Sieg, C Thoms, K Lüthgens, MR John, H Schmidt-Gayk International journal of colorectal disease 14 (6), 267-271, 1999 | 60 | 1999 |
| The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women SP Hämmerle, L Mindeholm, A Launonen, B Kiese, R Loeffler, E Harfst, ... Bone 50 (4), 965-973, 2012 | 57 | 2012 |
| Trajectory of cartilage loss within 4 years of knee replacement–a nested case–control study from the Osteoarthritis Initiative F Eckstein, RM Boudreau, Z Wang, MJ Hannon, W Wirth, S Cotofana, ... Osteoarthritis and cartilage 22 (10), 1542-1549, 2014 | 56 | 2014 |
| Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist KB Jonsson, MR John, RC Gensure, TJ Gardella, H Jüppner Endocrinology 142 (2), 704-709, 2001 | 55 | 2001 |
| A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma MR John, H Wickert, K Zaar, KB Jonsson, A Grauer, P Ruppersberger, ... Bone 29 (4), 393-402, 2001 | 52 | 2001 |
| Differential induction of proto-oncogene expression and cell death in ocular tissues following ultraviolet irradiation of the rat eye H Wickert, K Zaar, A Grauer, M John, M Zimmermann, F Gillardon British journal of ophthalmology 83 (2), 225-230, 1999 | 52 | 1999 |
| Identification and characterization of the zebrafish and fugu genes encoding tuberoinfundibular peptide 39 MR Papasani, RC Gensure, YL Yan, Y Gunes, JH Postlethwait, ... Endocrinology 145 (11), 5294-5304, 2004 | 51 | 2004 |